Tuesday, January 05, 2021

Propolis May Help Treat Diabetes, Obesity, Cancer (Cytokines, Inflammation, Fat, Diet, Cholesterol, COVID-19)




Biomedical Properties of Propolis on Diverse Chronic Diseases and Its Potential Applications and Health Benefits

NUTRIENTS

The use of alternative medicine products has increased tremendously in recent decades and it is estimated that approximately 80% of patients globally depend on them for some part of their primary health care. Propolis is a beekeeping product widely used in alternative medicine. It is a natural resinous product that bees collect from various plants and mix with beeswax and salivary enzymes and comprises a complex mixture of compounds. Various biomedical properties of propolis have been studied and reported in infectious and non-infectious diseases. However, the pharmacological activity and chemical composition of propolis is highly variable depending on its geographical origin, so it is important to describe and study the biomedical properties of propolis from different geographic regions. A number of chronic diseases, such as diabetes, obesity, and cancer, are the leading causes of global mortality, generating significant economic losses in many countries. In this review, we focus on compiling relevant information about propolis research related to diabetes, obesity, and cancer. The study of propolis could generate both new and accessible alternatives for the treatment of various diseases and will help to effectively evaluate the safety of its use...


Conclusions

Traditional and alternative medicine is the world’s oldest form of health care and is used in the prevention and treatment of physical and mental illnesses in the present day. Propolis is a beekeeping product widely used in alternative medicine due to its easy accessibility. In this review, we compiled some of the biomedical properties of propolis, focusing mainly on diabetes, obesity, and cancer. Our search for information reflects the global trend to seek new alternatives for the treatment of these diseases. There is a significant volume of research on propolis that shows that it is able to help in the control of diabetes by lowering glucose levels, MDA, and pro-inflammatory cytokines, and assisting in weight loss. Furthermore, it enhances serum insulin levels, the translocation of GLUT-4, and the function of antioxidant enzymes, in addition to protecting cells and pancreatic function. In obesity, propolis has also shown benefits, with in vitro and animal models providing evidence that it induces the transcription of adiponectin and leptin, reduces the mass of visceral adipose tissue, and regulates the levels of triglycerides, non-esterified fatty acids, and cholesterol. Another relevant aspect for propolis is the data obtained on its antitumor effects related to the inhibition of the cell cycle, apoptosis, proliferation, viability, growth, and cell migration; it is notable that many of these activities continue to have selectivity towards tumor cells without affecting non-tumor cells. It is necessary to emphasize that the propolis of each geographical region has different biomedical activities due to the significant diversity that exists in its chemical composition. As a result, each geographical variant of propolis can be considered a great source of natural products, particularly terpenes and phenolic compounds, such as flavonoids. Each propolis is thus unique, requiring individual study. Despite all the attributes and virtues of propolis, several challenges remain to overcome. The first is to determine a classification in which all the properties that have been studied can be integrated as well as those that emerge from future investigations. The proposal by Bankova (2005) can function as basis for achieving adequate classification [6]. The standardization of propolis will lead to its safe and adequate consumption, to achieve this it is necessary to generate a commitment from the scientific community that works with this beekeeping product to describe the chemical composition of all the propolis extracts used in any research. Another challenge is to increase in vivo and clinical studies, since much of the available evidence of the biomedical properties of propolis is in vitro work, which, in many cases, prevents the reported activities from being directly applied in humans. Furthermore, we consider that future clinical studies should use propolis with a well-established chemical composition, since this will allow the establishment of a specific dose for each disease and the adequate treatment in infectious and non-infectious diseases. Investigation and better understanding of the properties of propolis, and phenomena such as synergism and other mechanisms of natural products, can assist in the development of new and better medicines and safe consumption treatments as complementary therapies for these diseases.

No comments: